Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Insider Transactions

Date Name Title Type Shares Traded Price Range
May 14, 2018
Director
Director Open market or private sale of non-derivative or derivative security 9,275 $18.32
May 14, 2018
EVP, COO & CCO
EVP, COO & CCO Open market or private sale of non-derivative or derivative security 3,290 $18.10
May 14, 2018
EVP, COO & CCO
EVP, COO & CCO Other acquisition or disposition -- --
May 10, 2018
Director
Director Open market or private sale of non-derivative or derivative security 30,000 $17.55
May 10, 2018
Director
Director Other acquisition or disposition -- --
May 10, 2018
Director
Director Open market or private sale of non-derivative or derivative security 30,000 $17.13
May 10, 2018
Director
Director Other acquisition or disposition -- --
May 10, 2018
Director
Director Other acquisition or disposition -- --
May 10, 2018
Director
Director Other acquisition or disposition -- --
May 10, 2018
Director
Director Other acquisition or disposition -- --
May 10, 2018
Director
Director Other acquisition or disposition -- --
May 10, 2018
Director
Director Open market or private sale of non-derivative or derivative security 24,014 $18.38
May 07, 2018
Director
Director Other acquisition or disposition -- --
May 07, 2018
Director
Director Other acquisition or disposition -- --
May 07, 2018
Director
Director Open market or private sale of non-derivative or derivative security 30,000 $16.11
May 07, 2018
Director
Director Other acquisition or disposition -- --
May 07, 2018
Director
Director Open market or private sale of non-derivative or derivative security 30,000 $16.21
May 07, 2018
Director
Director Open market or private sale of non-derivative or derivative security 30,000 $15.98
May 07, 2018
Director
Director Other acquisition or disposition -- --
May 07, 2018
Director
Director Other acquisition or disposition -- --
May 07, 2018
Director
Director Other acquisition or disposition -- --
May 02, 2018
Director
Director Other acquisition or disposition -- --
May 02, 2018
Director
Director Other acquisition or disposition -- --
May 02, 2018
Director
Director Open market or private sale of non-derivative or derivative security 30,000 $16.04
May 02, 2018
Director
Director Open market or private sale of non-derivative or derivative security 30,000 $16.01

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Copyright Nasdaq. Minimum 15 minutes delayed.